VolitionRX Ltd (AMEX: VNRX) on Monday, plunged -9.41% from the previous trading day, before settling in for the closing price of $0.27. Within the past 52 weeks, VNRX’s price has moved between $0.27 and $0.94.
Annual sales at Healthcare sector company grew by 5.38% over the past five years. The company achieved an average annual earnings per share of 31.34%. With a float of $97.40 million, this company’s outstanding shares have now reached $109.62 million.
VolitionRX Ltd (VNRX) Insider and Institutional Ownership
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of VolitionRX Ltd is 20.69%, while institutional ownership is 21.27%. The most recent insider transaction that took place on Nov 17 ’25, was worth 7,000. In this transaction President and CEO of this company bought 20,000 shares at a rate of $0.35, taking the stock ownership to the 2,554,847 shares. Before that another transaction happened on Oct 14 ’25, when Company’s President and CEO bought 110,000 for $0.51, making the entire transaction worth $56,100. This insider now owns 2,534,847 shares in total.
VolitionRX Ltd (VNRX) Latest Financial update
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.06 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.05) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 31.34% per share during the next fiscal year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
VolitionRX Ltd (VNRX) is currently performing well based on its current performance indicators. A quick ratio of 0.12 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.12 in one year’s time.
Technical Analysis of VolitionRX Ltd (VNRX)
VolitionRX Ltd (AMEX: VNRX) saw its 5-day average volume 1.58 million, a positive change from its year-to-date volume of 0.52 million. As of the previous 9 days, the stock’s Stochastic %D was 10.47%.
During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 0.66%, which indicates a significant decrease from 3.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0288 in the past 14 days, which was lower than the 0.0409 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3922, while its 200-day Moving Average is $0.5511. Nevertheless, the first resistance level for the watch stands at $0.2632 in the near term. At $0.2827, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2943. If the price goes on to break the first support level at $0.2321, it is likely to go to the next support level at $0.2205. The third support level lies at $0.2010 if the price breaches the second support level.
VolitionRX Ltd (AMEX: VNRX) Key Stats
Market capitalization of the company is 29.93 million based on 122,802K outstanding shares. Right now, sales total 1,230 K and income totals -26,970 K. The company made 630 K in profit during its latest quarter, and -5,380 K in sales during its previous quarter.
